nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk
|
Mohammadnia, N. |
|
|
45 |
11 |
p. 1055-1059 |
artikel |
2 |
Atherosclerosis: More Challenging and Complex Than We Thought
|
Thompson, Peter L. |
|
|
45 |
11 |
p. 1017-1018 |
artikel |
3 |
Atherosclerotic Cardiovascular Disease in Women: Providing Protection With Lipid-altering Agents
|
Hiles, Megan |
|
|
45 |
11 |
p. 1127-1136 |
artikel |
4 |
Cognition and Cerebral Blood Flow After Extracranial Carotid Revascularization for Carotid Atherosclerosis: A Systematic Review
|
Kwok, C.H. Ricky |
|
|
45 |
11 |
p. 1069-1076 |
artikel |
5 |
Compatibility of Omadacycline With Select Parenteral Products in Simulated Y-site Administration
|
Butler, David A. |
|
|
45 |
11 |
p. 1137-1141 |
artikel |
6 |
Connecting the Dots: How Injury in the Arterial Wall Contributes to Atherosclerotic Disease
|
Belhoul-Fakir, Hanane |
|
|
45 |
11 |
p. 1092-1098 |
artikel |
7 |
Disulfiram-like Reaction With Ginaton: A Case Report and Literature Review
|
Dang, Xiangji |
|
|
45 |
11 |
p. 1151-1154 |
artikel |
8 |
Dynamic Regulatory Assessment: Unpacking the Process Reveals Readiness to Pilot for Europe—An EFPIA View
|
Todd, Iain |
|
|
45 |
11 |
p. 1142-1147 |
artikel |
9 |
Early Pharmacologic Approaches to Avert Anabolic Steroid-induced Male Infertility: A Narrative Review
|
Rizzuti, André |
|
|
45 |
11 |
p. e234-e241 |
artikel |
10 |
Editorial Board
|
|
|
|
45 |
11 |
p. i-ii |
artikel |
11 |
Effectiveness and Safety of Eliglustat Treatment in Gaucher Disease: Real-life Unicentric Experience
|
Duminuco, Andrea |
|
|
45 |
11 |
p. 1105-1110 |
artikel |
12 |
Effects of Transdermal 17β-Estradiol + Norethisterone Acetate on Cardiovascular Disease Risk Factors in Postmenopausal Women: A Meta-analysis of Data From Randomized, Controlled Trials
|
Lan, XiaoHong |
|
|
45 |
11 |
p. e222-e233 |
artikel |
13 |
Enhancing Risk Stratification on Coronary Computed Tomography Angiography: The Role of Artificial Intelligence
|
Jaltotage, Biyanka |
|
|
45 |
11 |
p. 1023-1028 |
artikel |
14 |
Exploring Barriers to Pediatric Cancer Clinical Trials: The Role of a Networked, Just-in-Time Study Program
|
Rivers, Zachary |
|
|
45 |
11 |
p. 1148-1150 |
artikel |
15 |
Global Trends in Atherosclerotic Cardiovascular Disease
|
Nedkoff, Lee |
|
|
45 |
11 |
p. 1087-1091 |
artikel |
16 |
Inclisiran for the Treatment of Hyperlipidemia and for Atherosclerotic Cardiovascular Disease Risk Reduction: A Narrative Review
|
Cowart, Kevin |
|
|
45 |
11 |
p. 1099-1104 |
artikel |
17 |
New Targets in Atherosclerosis: Vascular Smooth Muscle Cell Plasticity and Macrophage Polarity
|
Hutton, Michael |
|
|
45 |
11 |
p. 1047-1054 |
artikel |
18 |
Nirsevimab-alip
|
Beninger, Paul |
|
|
45 |
11 |
p. 1159-1160 |
artikel |
19 |
Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: Analysis of Number Needed To Treat and Number Needed To Harm
|
Sugarman, Ryan |
|
|
45 |
11 |
p. 1155-1158 |
artikel |
20 |
Pathology, Progression, and Emerging Treatments of Peripheral Artery Disease–Related Limb Ischemia
|
Golledge, Jonathan |
|
|
45 |
11 |
p. 1077-1086 |
artikel |
21 |
Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review
|
Bahit, M. Cecilia |
|
|
45 |
11 |
p. 1119-1126 |
artikel |
22 |
Peripheral Artery Disease: Underappreciated Impact and Residual Cardiovascular Risk Despite Revascularization
|
Jansen, Shirley |
|
|
45 |
11 |
p. 1019-1022 |
artikel |
23 |
Progress and Challenges of the New Conditional Approval Process in China: A Pooled Analysis From 2018 to 2021
|
Li, Jinlian |
|
|
45 |
11 |
p. 1111-1118 |
artikel |
24 |
Seeing Colchicine in a New Light: Repurposing Low-dose Colchicine for Secondary Prevention of Cardiovascular Disease
|
Nidorf, Stefan Mark |
|
|
45 |
11 |
p. 1029-1033 |
artikel |
25 |
The Impact of Artificial Intelligence on Coronary Imaging … and Beyond
|
Beninger, Paul |
|
|
45 |
11 |
p. 1015-1016 |
artikel |
26 |
The Promise of PCSK9 and Lipoprotein(a) as Targets for Gene Silencing Therapies
|
Chan, Dick C. |
|
|
45 |
11 |
p. 1034-1046 |
artikel |
27 |
Use of Silica Nanoparticles for Drug Delivery in Cardiovascular Disease
|
Kirla, Haritha |
|
|
45 |
11 |
p. 1060-1068 |
artikel |
28 |
What is Polypharmacy in Patients with Chronic Kidney Disease? A Systematic Review
|
Al-Khulaifi, Azhar |
|
|
45 |
11 |
p. e217-e221 |
artikel |